Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab

Summary

This study evaluates whether it is safe to administer a peptide vaccine in combination with pembrolizumab. This study will also evaluate the effects of the combination of the peptide vaccine and pembrolizumab on the immune system. The investigators will monitor these effects by performing tests in the laboratory on participants' blood, a lymph node, and tumor samples.

Timeline

Start

2016-10-06

Primary completion

2020-03-14

Completion

2020-03-14

Drugs

Indications